| abstract |
Provided are antibodies that bind and inhibit CD73, are capable of increasing the proliferation of T cells in the presence of CD39- expressing B cells and ATP. The disclosure also relates to cells producing such compounds; methods of making such compounds, and antibodies, fragments, variants, and derivatives thereof; pharmaceutical compositions comprising the same; methods of using the compounds to diagnose, treat or prevent cancer. |